NCT01528735 - This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Hepatitis C, Chronic

Interventions

DRUG

BI 207127 NA

one fix dose

DRUG

peginterferon

per package insert

DRUG

Ribavirin

per weight BID

DRUG

Ribavirin

per weight BID

DRUG

BI 207127 NA

one fix dose

DRUG

BI 201335 NA

high dose

DRUG

BI 201335 NA

low dose

DRUG

peginterferon

per package insert

Trial Locations (5)

1241.25.002 Boehringer Ingelheim Investigational Site, Kofu, Yamanashi

1241.25.005 Boehringer Ingelheim Investigational Site, Kurashiki, Okayama

1241.25.003 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1241.25.004 Boehringer Ingelheim Investigational Site, Nishinomiya, Hyogo

1241.25.001 Boehringer Ingelheim Investigational Site, Omura, Nagasaki